Shahram Lavasani
Company: ImmuneBiotech AB
Job title: Founder & CEO
Seminars:
Translational Precision Probiotics: From Concept to Marketing 3:30 pm
ImmuneBiotics™, new probiotic products designed with pharmaceutical precision Translational success of GutMagnific® – a multi-targeted therapeutic microbial consortium – from the lab to the clinic and to the commercial market Clinical evaluation of GutMagnific® in patients with post-viral fatigue – a condition considered as a long-term effect of COVID-19Read more
day: Focus Day
Immune Disease Panel Discussion – Developing Microbiome-Specific Translational Models 10:00 am
day: Focus Day